Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
Filter by:
Project name
Lead Institution
Summary
Funders
The Royal Marsden NHS Foundation Trust & The Francis Crick Institute
CAPTURE is a longitudinal, prospective cohort study in patient with cancer investigating immune responses after SARS-CoV-2 infection or COVID-19 vaccination.
The Royal Marsden Cancer Charity
The University of Nottingham
The aim of ACE study is to examine the immune responses to vaccination in young adults.
The National Core Studies Programme
The University of Oxford
VIBRANT will investigate why some people experience breakthrough infections, two or more infections or fail to mount an immune response following vaccination or natural infection.
UK Research and Innovation
Public Health England
The aim of SIREN is to find out whether healthcare workers who have evidence of prior COVID-19 are protected from future episodes of infection, compared to those who do not have evidence of infection.
National Institute of Health Research (NIHR), the UK Health Security Agency
University of Oxford
This study will help us understand the best way to immunise adolescents (12 to 16 years) against COVID-19.
UK Vaccine Task Force, National Institute of Health Research (NIHR), Novavax (vaccine supply)
University of Oxford
The purpose of this study is to test a new vaccine against COVID-19 in children and young adults aged 6-17 years.
National Institute for Health Research and AstraZeneca
University Hospitals for Bristol and Weston NHS Foundation Trust
This is a multicentre, randomised, observer-blind, active-controlled, superiority study to compare the immunogenicity of the Valneva and AstraZeneca vaccines.
Valneva Austria GmbH, Pharm-Olam International (UK) Ltd
University of Oxford
The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.
UK Research and Innovation (UKRI), National Institute for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations (CEPI), Engineering and Physical Sciences Research Council (EPSRC), NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland’s NIHR Clinical Research Network, AstraZeneca
University of Oxford
A phase I/II study to determine efficacy, safety and immunogenicity of the vaccine ChAdOx1 in UK healthy adults.
UK Research and Innovation (UKRI), National Institute for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations (CEPI), Engineering and Physical Sciences Research Council (EPSRC), NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland’s NIHR Clinical Research Network, German Center for Infection Research (DZIF)
University of Oxford
This is a single-blind trial to determine whether having doses of two different types of COVID-19 vaccines gives as good an immune system response as having two doses of the same vaccine.
UK Vaccine Task Force (VTF), National Institute Health Research (NIHR), Collaboration for Epidemic Preparedness (CEPI), Novavax (Vaccine supply)